Seer, Inc. (SEER)

NMS – Цена в реальном времени. Валюта: USD

1.66

-0.07 (-4.05%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

1.68

+0.02 (1.20%)

После закрытия: Jun 26, 2026, 4:25 PM EDT

15.06.2026

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group” or “we”), who collectively own approximately 7.7% of the outstanding shares of Seer, Inc. (NASDAQ: SEER) (“Seer” or the “Company”), today issued the following statement: “When Seer filed its proxy statement, the Board issued a 4,000-word letter to stockholders that we believe was a collection of inaccurate and misleading statements. In fact, the letter ended with the.

15.06.2026

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Urges Stockholders to Vote “FOR” ONLY Seer's Director Nominees on the BLUE Proxy Card Urges Stockholders to Vote “FOR” ONLY Seer's Director Nominees on the BLUE Proxy Card

03.06.2026

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Reinforces Seer's Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity Illustrates Why Radoff and Torok's Short-Term Campaign Risks Disrupting Seer's Momentum and Undermines Stockholder Value Urges Stockholders to Vote “FOR” ONLY Seer's Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission in connection with the Company's upcoming Annual Meeting of Stockholders (the “Annual Meeting”) to be held on July 28, 2026.

29.05.2026

Seer Files ITC Complaint Against Nanomics

Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations

27.05.2026

The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders

HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group” or “we”), who collectively own approximately 7.8% of the outstanding shares of Seer, Inc. (NASDAQ: SEER) (“Seer” or the “Company”), today issued the following open letter to the Company's independent directors and financial and legal advisors in response to Seer's apparent bad-faith rejection of the Radoff-JEC Group's three fully financed proposals to acquire Seer. Th.

26.05.2026

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

REDWOOD CITY, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation at the 2026 American Society for Mass Spectrometry (ASMS) Annual Conference, taking place May 31 to June 4 at the San Diego Convention Center.

21.05.2026

Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group

REDWOOD CITY, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (the “Board”) has thoroughly reviewed and unanimously rejected the further revised unsolicited non-binding proposal received on May 14, 2026, from Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group”), to acquire all of the outstanding shares of Seer's Class A common stock for $2.40 per share in cash plus a contingent value right (the “May 14 Revised Proposal”).

Видео

No Data

There is no data to display

Пресс-релизы

15.06.2026

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

15.06.2026

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Urges Stockholders to Vote “FOR” ONLY Seer's Director Nominees on the BLUE Proxy Card Urges Stockholders to Vote “FOR” ONLY Seer's Director Nominees on the BLUE Proxy Card

03.06.2026

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

29.05.2026

Seer Files ITC Complaint Against Nanomics

Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations

Seer, Inc. (SEER)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Seer, Inc. (SEER)

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics

The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group

Видео

No Data

Пресс-релизы

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics

The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group

Видео

No Data

Пресс-релизы

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics

Search stocks

Seer, Inc. (SEER)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Seer, Inc. (SEER)

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics

The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group

Видео

No Data

Пресс-релизы

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics

The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group

Видео

No Data

Пресс-релизы

The Radoff-JEC Group Highlights Seer Inc.'s and Chairman and CEO Omid Farokhzad, M.D.'s History of Value Destruction

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company's Significant Scientific Progress and Addressing Radoff and Torok's Short-Sighted Campaign

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

Seer Files ITC Complaint Against Nanomics